The Effect of Education on Nurses' Knowledge About High-flow Nasal Cannula Oxygen Therapy
May 4, 2022 updated by: Aslı Alaca, Izmir Katip Celebi University
The Effect of Training on Oxygen Therapy With High Flow Nasal Cannula on the Knowledge Level of Pediatric Nurses; A Randomized Controlled Trial
This study was conducted to evaluate the oxygen therapy methods used in pediatric services and to specify the roles and responsibilities of nurses in the application of HFNC, which is one of these methods.
Although the decision to implement this treatment method is under the responsibility of the physician in Turkey, the use of the device, observing the effectiveness of the treatment, monitoring and recording the changes in the vital signs of the children are under the responsibility of the nurses shows the importance of the nursing perspective on HFNC.
Study Overview
Detailed Description
High-flow nasal cannula oxygen therapy (HFNC) which meets the patient's ventilation need is a non-invasive ventilation system in which warmed and humidified oxygen is administered to the patient at varying flows with the help of a nasal cannula.This study will be conducted as a randomized controlled study with the participation of 70 nurses working in the pediatric clinics of a public hospital between December 2021 and May 2022, as an experimental group (n=35) and a control group (n=35).
In the study, two-stage sampling method will be used to determine the nurses who will take place in the experimental and control groups.
After the nurses are stratified according to their professional years, assignment to the experimental and control groups will be made by simple random sampling method.
The experimental group will be given a pre-test before the training and a post-test one month after the training.
In order to avoid interaction between the two groups, the data of the nurses in the control group will be collected first.
The knowledge level of the nurses in the experimental and control groups will be evaluated with the HFNC Information Form.
Study Type
Interventional
Enrollment (Anticipated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Aslı Alaca
- Phone Number: +905052741676
- Email: alaca_asli_1992@hotmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Nurses working in any of the pediatric emergency departments, pediatric clinics
- No previous training in HFNC treatment
- Follow-up of patients treated with HFNC
- Volunteering to participate in research
Exclusion Criteria:
- Those who have received in-service training on HFNC implementation
- Those who work as responsible nurses or training nurses in the clinics where the research will be conducted
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Test after post-test training
Pre-test will be applied to the nurses in the experimental group before the training.
The post-test will be applied to the experimental group, to which the pre-test was applied, one month after the training was given.
|
One month after the pre-test, the post-test will be administered to the nurses who will be in the control group. Nurses who will be in the experimental group will be given training after the pre-test. A post-test will be administered one month after the training. |
|
No Intervention: Test without training
The nurses in the control group are the group to be administered the post-test without any intervention after the pre-test.
The post-test will be administered one month after the pre-test.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge Level - Education Form- Questionnaire
Time Frame: One month after training
|
To increase the knowledge level of nurses about oxygen therapy with high flow nasal cannula.
|
One month after training
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Aslı ALACA, study principal investigator
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
May 10, 2022
Primary Completion (Anticipated)
June 10, 2022
Study Completion (Anticipated)
August 10, 2022
Study Registration Dates
First Submitted
April 23, 2022
First Submitted That Met QC Criteria
May 4, 2022
First Posted (Actual)
May 5, 2022
Study Record Updates
Last Update Posted (Actual)
May 5, 2022
Last Update Submitted That Met QC Criteria
May 4, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AAlaca
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.